Journal Information

Statistics

Follow this link to access the full text of the article

437
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY
A. Maiolinoa, P. Moreaub, M. Dimopoulosc, J. Mikhaeld, K. Yonge, M. Capraf, T. Facong, R. Hajekh, I. Spickai, M. Rissej, G. Assetk, S. Macél, T. Martinm
a Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
b University Hospital Hôtel-Dieu, Nantes, France
c The National and Kapodistrian University of Athens, Athens, Greece
d Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, United States
e University College Hospital, London, United Kingdom
f Hospital Mãe de Deus, Porto Alegre, RS, Brazil
g Lille University Hospital, Lille, France
h University Hospital Ostrava, Ostrava, Czech Republic
i Charles University in Prague, Prague, Czech Republic
j Sanofi R&D, Vitry/Alfortville, France
k Sanofi R&D, Chilly-Mazarin, France
l Sanofi R&D, Vitry/Alfortville, France
m University of California at San Francisco, San Francisco, United States
Ver más
Read
2450
Times
was read the article
1169
Total PDF
1281
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 5 4 9
2025 6 52 23 75
2025 5 45 13 58
2025 4 37 11 48
2025 3 41 13 54
2025 2 43 21 64
2025 1 32 30 62
2024 12 26 18 44
2024 11 35 17 52
2024 10 23 16 39
2024 9 27 14 41
2024 8 27 23 50
2024 7 14 18 32
2024 6 20 18 38
2024 5 20 22 42
2024 4 16 22 38
2024 3 18 18 36
2024 2 21 19 40
2024 1 16 18 34
2023 12 21 29 50
2023 11 34 34 68
2023 10 12 22 34
2023 9 17 24 41
2023 8 7 15 22
2023 7 21 13 34
2023 6 19 20 39
2023 5 23 10 33
2023 4 12 6 18
2023 3 19 13 32
2023 2 19 13 32
2023 1 16 6 22
2022 12 20 15 35
2022 11 30 24 54
2022 10 24 21 45
2022 9 26 22 48
2022 8 12 30 42
2022 7 33 26 59
2022 6 13 19 32
2022 5 17 18 35
2022 4 9 23 32
2022 3 17 17 34
2022 2 18 21 39
2022 1 15 15 30
2021 12 12 25 37
2021 11 16 20 36
2021 10 26 53 79
2021 9 18 28 46
2021 8 27 39 66
2021 7 24 25 49
2021 6 20 31 51
2021 5 25 34 59
2021 4 41 34 75
2021 3 27 32 59
2021 2 20 19 39
2021 1 20 13 33
2020 12 14 8 22
2020 11 19 14 33
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy